Unicycive Therapeutics's total assets for Q1 2025 were $27.95M, a decrease of -11.75% from the previous quarter. UNCY total liabilities were $16.68M for the fiscal quarter, a -31.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.